Valeant continues Russian spending spree with $180m Natur Produkt buy

Valeant Pharmaceuticals International Inc. saw its stock price tick up slightly after announcing its $180 million purchase of Russian over-the-counter cold remedy company Natur Produkt.

More from Alimentary/Metabolic

More from Therapeutic Category